BRC News

Steve blood taken.jpg

UCL BioResource got a kick start last week with one of its first recruits – BRC staff member Dr Steve Heggie.
Test Tubes photo bucket.jpg

UCL and UCLH researchers are to start a new multi-site clinical trial of three re-purposed drugs to assess whether they can be used to treat multiple sclerosis (MS).
Spinal cord.jpg

An international team, including BRC-supported researchers, has found evidence that patients already have irreversible tissue loss within 40 days of a spinal cord injury. Image courtesy of Bill McConkey, Wellcome Images 
Brain_0.jpg

An international team of researchers has shown why people with a variation of the FTO gene affecting one in six of the population are 70 per cent more likely to become obese. A new study led by BRC-supported researcher Dr Rachel Batterham, and including scientists from UCL, the Medical Research
MS_0.jpg

BRC-supported researchers have identified a likely cause of damage to the nerves in multiple sclerosis (MS), opening up the possibility of treatments to prevent the disabling symptoms of this neurodegenerative disease. Image courtesy of Professor Peter Brophy, Wellcome Images 
Wristwatch_0.jpg

Researchers are about to start a new study to see if a sensor worn on the wrist to measure blood pressure is a better way of determining who needs treatment to lower their blood pressure.
MRI__square_.jpg

A new technique for detecting cancer by imaging the consumption of sugar using MRI has been unveiled by a team of scientists at UCL, including a BRC-supported researcher.
Usha.jpg

Cancer Research UK and its commercial arm, Cancer Research Technology (CRT), have joined forces with biomarker validation company Abcodia and the UK Collaborative Trial for Ovarian Cancer Screening (UKCTOCS) biobank to develop new blood tests to detect a range of cancers at a very early stage.
Prostate cancer cells.jpg

A BRC researcher and his team have suggested that using MRI imaging before deciding whether to carry out a biopsy on patients with suspected prostate cancer may lead to improved outcomes for men with the disease. Image courtesy of Annie Cavanagh, Wellcome Images